Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Couet

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1991
Pharmacokinetics of oral cefatrizine in patients with impaired renal functionW Couet, J P Fauvel, M Laville, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious ratsI Smolders, C Gousseau, S Marchand, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of imipenem in rats with experimental hypovolaemia or endotoxaemiaA Limosin, A Dupuis, I Lamarche, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophyllineW Couet, I Ingrand, B Reigner, et al.
Pharmaceutical Research|January 22, 2000
Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicityJ C Olivier, L Fenart, R Chauvet, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effect of ponsinomycin on cyclosporin pharmacokineticsW Couet, B Istin, P Seniuta, et al.
Pathologie-Biologie|May 1, 1988
[Pharmacokinetics of cefatrizine administered in repeated doses]W Couet, B G Reigner, M A Lefebvre, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in ratsA Delon, F Huguet, P Courtois, et al.
Pathologie-Biologie|May 1, 1989
[Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers]W Couet, J Girault, B Reigner, et al.
Pathologie-Biologie|May 1, 1989
[Influence of food intake on the bioavailability of ponsinomycin administered in a syrup form]J B Fourtillan, W Couet, I Ingrand, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1991
Pharmacokinetics of oral cefatrizine in patients with impaired renal functionW Couet, J P Fauvel, M Laville, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious ratsI Smolders, C Gousseau, S Marchand, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of imipenem in rats with experimental hypovolaemia or endotoxaemiaA Limosin, A Dupuis, I Lamarche, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophyllineW Couet, I Ingrand, B Reigner, et al.
Pharmaceutical Research|January 22, 2000
Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicityJ C Olivier, L Fenart, R Chauvet, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effect of ponsinomycin on cyclosporin pharmacokineticsW Couet, B Istin, P Seniuta, et al.
Pathologie-Biologie|May 1, 1988
[Pharmacokinetics of cefatrizine administered in repeated doses]W Couet, B G Reigner, M A Lefebvre, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in ratsA Delon, F Huguet, P Courtois, et al.
Pathologie-Biologie|May 1, 1989
[Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers]W Couet, J Girault, B Reigner, et al.
Pathologie-Biologie|May 1, 1989
[Influence of food intake on the bioavailability of ponsinomycin administered in a syrup form]J B Fourtillan, W Couet, I Ingrand, et al.
Pageof 6